XEMA Group
Lappeenranta, Finland· Est.
XEMA delivers ELISA and rapid immunoassay kits for clinical, veterinary, food safety, and forensic diagnostics worldwide.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
XEMA delivers ELISA and rapid immunoassay kits for clinical, veterinary, food safety, and forensic diagnostics worldwide.
OncologyInfectious DiseasesEndocrinologyAllergyVeterinaryFood Safety
Technology Platform
Immunoassay platforms based on ELISA and lateral‑flow technologies, supported by in‑house production of monoclonal/polyclonal antibodies, antigens, and HRPO/fluorescent conjugates.
Opportunities
Expansion into emerging markets and the growing halal‑certified food testing sector, plus development of digital read‑out platforms for rapid tests.
Risk Factors
Regulatory hurdles across multiple jurisdictions and intense competition from large IVD manufacturers with broader portfolios.
Competitive Landscape
XEMA competes with global IVD leaders such as Abbott, Roche, and Thermo Fisher, differentiating itself through specialised halal testing, rapid LF formats, and custom antibody production.